Preliminary Report: Vitamin D Deficiency in Advanced Cancer Patients with Symptoms of Fatigue or Anorexia
Authors:
Open Access
- 30 September 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 16 (11) , 1637-1641
Abstract
Background.: Vitamin D deficiency in noncancer patients is associated with symptoms of fatigue, muscle weakness, and depression. These symptoms are common among advanced cancer patients. We investigated the prevalence of low serum vitamin D levels in cancer patients with fatigue or poor appetite and their association with symptom burden and other correctable endocrine abnormalities.Methods.: This was a retrospective review of 100 consecutive cancer patients with appetite or fatigue scores of ≥4 of 10 referred to a supportive care clinic. We investigated serum levels of 25(OH) vitamin D, cortisol, thyroid-stimulating hormone, and bioavailable testosterone. Symptoms were measured by the Edmonton Symptom Assessment Scale. Serum 25(OH) vitamin D <20 ng/mL was considered deficient; ≥20 ng/mL and <30 ng/mL were considered insufficient.Results.: Patients were predominantly male (68%) and white (66%), with a median age of 60 years (range, 27–91 years). Gastrointestinal (30%) and lung (22%) cancers were predominant. Forty-seven patients (47%) were vitamin D deficient and 70 (70%) were insufficient. Thirteen of 70 patients (19%) with vitamin D insufficiency were on supplementation. Vitamin D deficiency was more common among nonwhites (82% versus 36%) and females. No significant association was found between vitamin D and symptoms. Hypogonadic males had a significantly lower mean 25(OH) vitamin D level than eugonadic males.Conclusions.: Low vitamin D levels were highly prevalent among advanced cancer patients with cachexia or fatigue. Vitamin D deficiency was more frequent among nonwhite and female patients. Vitamin D levels were also significantly lower in male patients with hypogonadism.Keywords
Funding Information
- National Institutes of Health (RO1NR010162–01A1, RO1CA1222292.01, RO1CA124481–01)
- American Cancer Society (PEP-08–299-01-PC1)
This publication has 37 references indexed in Scilit:
- Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot studyCritical Care, 2011
- Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncologyNutrition Journal, 2010
- A Randomized Controlled Trial of the Effects of Vitamin D on Muscle Strength and Mobility in Older Women with Vitamin D InsufficiencyJournal of the American Geriatrics Society, 2010
- Hypothalamic mechanisms in cachexiaPhysiology & Behavior, 2010
- Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast CancerJournal of Clinical Oncology, 2009
- Association between serum 25(OH)D and death from prostate cancerBritish Journal of Cancer, 2009
- Circulating 25-Hydroxyvitamin D, VDR Polymorphisms, and Survival in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2008
- Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancerInternational Journal of Colorectal Disease, 2008
- Additive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and womenOsteoporosis International, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007